|
|
|
|
|
Michelle Wright visits West Mifflin Imaging
Click here to see Michelle Wright's report on virtual colonoscopies,
full-body scans and cardiac CTs performed at West Mifflin Imaging.

|
|
|
|
|

|
|
|
3 in one screening
3 in one Screening
Stroke Screening / Carotid Arteries
Carotid Artery blockage is the #1 Cause of Stroke
Abdominal Aortic Aneurysm
Screening Majority of People Who Have an Aneurysm Have No Symptoms
Periphial Arteriol Disease Screening
Checks for plague in arms & legs
"Bonus"Bone Density Testing
All for only $129.00
Save Hundreds of Dollars
Call now to schedule
|
|
|
|
|
|
|
|
|
|
| CT Angiography Proves to be
an Effective Diagnostic Tool for Chest Pain |
|
|
Nearly six million people
visit the emergency room for chest pain each year in the United States, and
somewhere between four to 13 percent of those patients are misdiagnosed and
sent home when, in fact, they had suffered a heart attack.
CT angiography, better known simply
as a CT scan, is a rapid diagnostic tool that has shown to be a more
efficient diagnostic tool when it comes to locating blocked arteries in
patients complaining of chest pain. In fact, a CT scan is as safe as other
diagnostic techniques, such as electrocardiograms and resting stress tests,
and is often faster and less expensive, according to a recent American Heart
Association scientific meeting.
In fact, a recent study conducted
at William Beaumont Hospital in Royal Oak, Michigan followed 701 patients
and found that CT scans, in general, take about half the time to complete as
other diagnostic techniques and shave off nearly 40 percent of the cost of
making the diagnosis.
Many times, doctors use
electrocardiograms and resting stress tests, combined with nuclear imaging,
to diagnose blocked arteries. Both of these tests take time and many times
fail to provide a definitive diagnosis, says lead author of the study,
Kavitha Chinnaiyan.
The researchers of the study, with
this knowledge in mind, began to try CT angiography, which takes multiple
x-rays of the coronary arteries. The result: quicker diagnoses of blocked
coronary arteries.
|
|
|
|
| Recent CT Study Fails to
Recognize Benefits |
|
|
December 15, 2009
A recent study reported that the
radiation exposure from CT scans may lead to a higher risk of cancer in some
people. Many radiologists, as a result, are worried that this newest study
in the Archives of Internal Medicine may deter some patients from receiving
this important diagnostic tool.
CT scans provide doctors with a
clear view of the inside of the body, and are often much more helpful than
traditional x-rays, yet they do involve a much higher amount of radiation
dose than conventional x-rays. However, according to an article in Reuters,
many radiology specialists have emphasized that the chances of an individual
getting cancer from a single CT scan is still very low.
Because CT scans are often an
excellent tool for detecting such serious health conditions as tumors and
heart disease, it is clear to many radiologists and doctors that the
advantages of CT scans clearly outweigh the risks.
In fact, the American College of
Radiology, which is a group of nearly 34,000 doctors specializing in
radiology, recently stated that: “No published studies show that radiation
from imaging exams causes cancer.“
They went onto say that: “Most CT
is performed in controlled settings and results in limited radiation
exposure to a small portion of the body.”
The use of CT scans have increased
greatly in America, increasing from about three million scans in 1980 to
nearly 70 million scans in 2007.
|
|
|
|
|
|
|
|
| American Heart Association
Endorses Calcium Scores |
|
|
December 28, 2009
Calcium scores, which have often
been identified by many doctors as effective screening tools for coronary
heart disease, are now endorsed by the American Heart Association.
CT scans are often a useful
screening tool for detecting the presence of calcium deposits in the lining
of the coronary arteries, and the multi-slice CT scans (West Mifflin Imaging
employs a 64-slice CT scanner – often recognized as a leader in the
industry) have been useful in detecting discrete blockages in coronary
arteries. However, the American Heart Association (AHA), as well as the
federal government, has been hesitant to endorse calcium scores because
there has simply been a lack of data proving their worth in detecting
coronary heart disease.
However, an American Heart
Association writing group recently announced that it recommends CT scans for
detecting calcium deposits in the coronary arteries of those individuals who
are at an increased risk of coronary heart disease.
Many experts in the field of CT
expect that the AHA will continue its endorsement of calcium scores as
technology improves and clinical trials are completed.
|
|
|
|
|
|
|
| Newly Released Mammography
Recommendations under Scrutiny |
|
|
|
November 17, 2009
November 16 was a day of surprise, shock and general
unrest throughout much of the country as news spread about changes to
mammography guidelines that have been in place since 2003.
These new guidelines, which were released by the United
States Preventative Services Task Force (USPSTF), state that annual,
preventative mammographic screenings for women between 40 and 49 are no
longer necessary. The Task Force also recommends that women only start
receiving regular mammograms at the age of 50 and, even then, should get the
test every two years instead of on an annual basis.
These latest recommendations have left many patients
confused, many breast cancer survivors stunned, and many doctors and experts
in the field of mammography and breast cancer more than a bit unnerved.
The Task Force, which makes up a government panel of
doctors and scientists, concluded in its study that mammography in younger
women often leads to more false-positives and unnecessary worry and anxiety.
The study also points out that many unneeded biopsies result from screening
younger women.
Some of the groups that have spoken
out against these newly released guidelines by the USPSTF include: the
American Cancer Society, the National Cancer Institute and the American
College of Obstetricians and Gynecologists. These groups, among others, have
announced that they will not change their guidelines and will continue to
urge women to follow the current guidelines of routine, mammographic
screenings for all women age 40 and older.
The American Cancer Society issued a
statement in response to the release of the USPSTF’s guidelines, saying:"The
American Cancer Society continues to recommend annual screening using
mammography and clinical breast examination for all women beginning at age
40. Our experts make this recommendation having reviewed virtually all the
same data reviewed by the USPSTF, but also additional data that the USPSTF
did not consider."
For breast cancer survivors who
were diagnosed before the age of 50, there is a general sense of outrage
that the new guidelines released by the USPSTF will surely result in more
breast cancer deaths among young women. And for the vast majority of
doctors, experts and women, these guidelines are simply unacceptable.
|
|
|
|
|
|
American Cancer Society Responds to
Changes in USPSTF Mammography Guidelines |
|
|
As it appears on the American Cancer Society’s website:
www.cancer.org
November 16,
2009
The United States Preventative
Services Task Force (USPSTF) today announced that it is changing its
guidelines for mammography and no longer recommends routine screening for
women between the ages of 40 and 49. Below is a statement from Otis W.
Brawley, M.D., chief medical officer, American Cancer Society.
“The American Cancer Society
continues to recommend annual screening using mammography and clinical
breast examination for all women beginning at age 40. Our experts make this
recommendation having reviewed virtually all the same data reviewed by the
USPSTF, but also additional data that the USPSTF did not consider. When
recommendations are based on judgments about the balance of risks and
benefits, reasonable experts can look at the same data and reach different
conclusions.
“In 2003, an expert panel
convened by the American Cancer Society conducted an extensive review of the
data available at the time, which was not substantially different from the
data included in the current USPSTF review. Like the USPSTF, the Society’s
panel found convincing evidence that screening with mammography reduces
breast cancer mortality in women ages 40-74, with age-specific benefits
varying depending on the results of individual trials and which trials were
combined in meta-analyses. And like the USPSTF, the American Cancer Society
panel also found that mammography has limitations – some women who are
screened will have false alarms; some cancers will be missed; and some women
will undergo unnecessary treatment. These limitations are somewhat greater
in women in their forties compared with women in their fifties, and somewhat
greater in women in their fifties compared with women in their sixties. We
specifically noted that the overall effectiveness of mammography increases
with increasing age. But the limitations do not change the fact that breast
cancer screening using mammography starting at age 40 saves lives. “As
someone who has long been a critic of those overstating the benefits of
screening, I use these words advisedly: this is one screening test I
recommend unequivocally, and would recommend to any woman 40 and over, be
she a patient, a stranger, or a family member.
“The USPSTF says that
screening 1,339 women in their 50s to save one life makes screening
worthwhile in that age group. Yet USPSTF also says screening 1,904 women
ages 40 to 49 in order to save one life is not worthwhile. The American
Cancer Society feels that in both cases, the lifesaving benefits of
screening outweigh any potential harms. Surveys of women show that they are
aware of these limitations, and also place high value on detecting breast
cancer early.
“With its new recommendations, the
USPSTF is essentially telling women that mammography at age 40 to 49 saves
lives; just not enough of them. The task force says screening women in their
40s would reduce their risk of death from breast cancer by 15 percent, just
as it does for women in their 50s. But because women in their 40s are at
lower risk of the disease than women 50 and above, the USPSTF says the
actual number of lives saved is not enough to recommend widespread
screening. The most recent data show us that approximately 17 percent of
breast cancer deaths occurred in women who were diagnosed in their 40s, and
22 percent occurred in women diagnosed in their 50s. Breast cancer is a
serious health problem facing adult women, and mammography is part of our
solution beginning at age 40 for average risk women.
“The American Cancer Society
acknowledges the limitations of mammography, and we remain committed to
finding better tests, and currently are funding a large study to improve the
accuracy of mammography. In fact, data show the technology used today is
better than that used in the studies in this review, and more modern studies
show that mammography is achieving better results than those achieved in
these early experimental studies that go back as far as the mid-60’s. And as
scientists work to make mammography even more effective, the American Cancer
Society’s medical staff and volunteer experts overwhelmingly believe the
benefits of screening women aged 40 to 49 outweigh its limitations.”
The American Cancer Society
combines an unyielding passion with nearly a century of experience to save
lives and end suffering from cancer. As a global grassroots force of more
than three million volunteers, we fight for every birthday threatened by
every cancer in every community. We save lives by helping people stay well
by preventing cancer or detecting it early; helping people get well by being
there for them during and after a cancer diagnosis; by finding cures through
investment in groundbreaking discovery; and by fighting back by rallying
lawmakers to pass laws to defeat cancer and by rallying communities
worldwide to join the fight. As the nation’s largest non-governmental
investor in cancer research, contributing about $3.4 billion, we turn what
we know about cancer into what we do. As a result, more than 11 million
people in America who have had cancer and countless more who have avoided it
will be celebrating birthdays this year. To learn more about us or to get
help, call us anytime, day or night, at 1-800-227-2345 or visit cancer.org.
|
|
|
|
|
| Few Serious Reactions
Reported with CT and MRI Contrast |
|
|
October 30, 2009
Although there has been plenty of
talk in the industry regarding CT and MRI contrast and serious reactions, a
new study by the Mayo Clinic in Rochester, MN, which was recently released
in the October issue of the American Journal of Roentgenology, found that
few patients experience adverse reactions.
In fact, the researchers of the
study found that there were only 19 cases (or less than 1 percent) of severe
reactions to CT and MRI contrast over a four-year period, from 2002 to 2006.
Given the fact that there were nearly a half million administrations of
low-osmolar iodinated CT contrast and gadolinium-based MRI agents during
this time, this number signifies an extremely low adverse event rate.
In addition, the study also found
that most reactions to CT and MRI contrast were mild in nature and were
easily managed within the radiology department. The study went onto indicate
that additional treatment and emergency treatment were rarely required.
The study defined reactions as
occurring in the radiology suite both during the contrast administration and
30 minutes following the administration of the contrast.
Of the 522 cases of adverse affects
the study found, a large majority of the patients (423) experienced mild
nausea, vomiting and rash. In addition, 458 cases were associated with
low-osmolar iodinated contrast, while just 64 cases were reported with
gadolinium contrast.
The Mayo Clinic study, however,
went onto say that a risk still exists when using contrast agents and that
“careful review of reporting and treatment protocol is necessary to prevent
morbidity and mortality.”
|
|
|
|
|
| Second Breast Cancers and
Lifestyle Factors Continue to Show Strong Link |
|
|
November 1, 2009
A recent study by the Journal of Clinical Oncology further solidifies the link between second breast cancer and certain lifestyle factors, including obesity, alcohol consumption and smoking.
The researchers of the study, which involved 365 women who were diagnosed with an estrogen-receptor-positive first primary breast cancer and later a second primary breast cancer, as well as 726 matched controls who were diagnosed with only an ER-positive primary breast cancer, studied patients according to obesity, alcohol consumption and smoking.
Findings of the study:
• Women who were medically obese were 50 percent more likely to develop a second breast cancer than women who were not medically obese.
• Women who consumed more than seven alcoholic drinks per week after their first breast cancer diagnosis were 70 percent more likely to develop a second breast cancer than women who did not drink alcohol.
• Women who smoked were more than twice as likely to develop a second breast cancer as women who did not smoke.
The study concluded that certain lifestyle factors could lead to higher incidences of second breast cancer, and that breast cancer survivors can make lifestyle changes to reduce their risk of developing a second breast cancer.
|
|
|
|
|
| Strong Link Found Breast
Cancer Mortality and Non-Screened Women |
|
|
October 29, 2009
The 2009 Breast Cancer Symposium, which was recently held in San Francisco, released a recent study which found that mammographic screening still continues to be a woman’s best defense against breast cancer mortality.
The study was headed by lead author Dr. Blake Cady from Cambridge Hospital Breast Center, Massachusetts, who spoke to attendees at the Breast Cancer Symposium about the latest breast cancer mortality findings.
The study detailed 6,997 women who were diagnosed with invasive breast cancer in Massachusetts from 1990 to 1999; the women were followed through 2007, or a twelve-and-a-half-year period.
During that period, 461 breast cancer deaths were reported and, of those deaths, nearly 75 percent were in women who did not receive regular, mammographic screening. Twenty-five percent of those deaths were in regularly screened women.
Regular, mammographic screening was defined as having at least two mammograms during a two-year-or-less period in asymptomatic women.
Dr. Cady concluded that “the most effective method for women to avoid death from breast cancer is to have regular mammographic screening.”
|
|
|
|
|
|
|
|
|
| |